Meitheal Pharmaceuticals recalls

Meitheal Pharmaceuticals has 3 recalls on record with the FDA and USDA, the earliest in 2021 and the latest reported on 18 Feb 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is labeling errors.

Total recalls3since 2021

Last 12 months1reported

Class I133% of total

Ongoing1latest 18 Feb 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 1Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 1 33%Class II 1 33%Class III 1 33%

Why meitheal pharmaceuticals is recalled

Product types

Injectable & IV Drugs3100%

By year

2026133%
2021267%

Ongoing meitheal pharmaceuticals recalls

1 active

Reported	Class	Recall	Company	Reason	Where
18 Feb 2026Drug	CLASS II	Cetrorelix Acetate for Injection , 0.25 mg per vial, Single-Dose Kit recalled	Meitheal Pharmaceuticals	Other	Nationwide

All meitheal pharmaceuticals recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
18 Feb 2026Drug	CLASS II	Cetrorelix Acetate for Injection , 0.25 mg per vial, Single-Dose Kit recalled	Meitheal Pharmaceuticals	Other	Nationwide
22 Sep 2021Drug	CLASS III	Glycopyrrolate Injection, USP 4mg per Multi-Dose Vials recalled	Meitheal Pharmaceuticals	Potency & Assay	Nationwide
3 Mar 2021Drug	CLASS I	Cisatracurium Besylate Injection, USP, 10mg recalledCisatracurium Besylate	Meitheal Pharmaceuticals	Labeling Errors	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.